October 24, 2014

Meet us at the Bio-Europe 2014 meeting in Frankfurt

Biogazelle participates at the Bio-Europe 2014 meeting in Frankfurt from November 3-5, 2014.
This forum creates the opportunity to discuss your gene expression projects and research partnerships.
Please send an email to info@biogazelle.com if you want to set up a meeting. We can then assess if our services can support your research. We are open to discuss subcontractor work for or partnerships in Horizon 2020 projects.

October 6, 2014

UGent spin-off Biogazelle attracts new investors QBIC Arkiv Fund, Foundation Majoie and SOFI to finance growth

Qbic Arkiv Fund, Foundation Majoie and SOFI invest 2.0 million EUR in UGent spin-off Biogazelle, a company that offers software and laboratory services for gene expression analysis. Biogazelle will primarily use the investment to further develop its research on therapeutic RNA targets for specific cancer types, and to expand its commercial activities.

October 1, 2013

Biogazelle serves as reference laboratory for Bio-Rad's droplet digital PCR system

Biogazelle today annouced that it is serving is a reference laboratory for Bio‑Rad’s QX200™ Digital Droplet PCR™ system (ddPCR) in Europe. This extends Biogazelle’s and Bio-Rad’s long-term partnership for PCR-based solutions. As a reference laboratory, Biogazelle uses ddPCR in its R&D programs and shares its ddPCR user experience with the PCR community. In addition, Biogazelle is acting as a ddPCR service provider for third parties who are interested in outsourcing a study.

October 22, 2012

Belgian company Biogazelle develops lab products beyond industry standards

Bio-Rad Laboratories recently launched a new product line that was designed in conjunction with the Belgian company Biogazelle. The new product line consists of 20,000 individual real-time PCR assays, known as PrimePCR assays, all of which have been validated beyond international lab standards by Biogazelle.